Perdoceo Education Corporation Stock News
$32.98
1.79%
yesterday
Nasdaq,
Jun 27, 10:05 pm CET
Perdoceo Education Corporation Stock News
Negative
Seeking Alpha
●
about one month ago
PRDO's recent earnings beat and raised guidance drove a stock surge, but the valuation now exceeds historical averages, raising caution. Despite strong financials and a capital-light, high-margin model, PRDO is highly dependent on federal funding and faces significant regulatory risk. The for-profit education sector is in structural decline, with negative public perception and tightening regula...
Neutral
Seeking Alpha
●
about 2 months ago
Perdoceo Education Corporation (PRDO) Q1 2025 Earnings Call Transcript
Neutral
Business Wire
●
about 2 months ago
SCHAUMBURG, Ill.--(BUSINESS WIRE)--PERDOCEO EDUCATION CORPORATION ANNOUNCES FIRST QUARTER 2025 RESULTS.
Neutral
Business Wire
●
2 months ago
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Perdoceo Education Corporation Schedules First Quarter Earnings Conference Call for May 1st.
Neutral
Seeking Alpha
●
4 months ago
Perdoceo Education Corporation (NASDAQ:PRDO ) Q4 2024 Earnings Conference Call February 18, 2025 5:00 PM ET Company Participants Nick Nelson - Alpha IR Todd Nelson - President and Chief Executive Officer Ashish Ghia - Senior Vice President and Chief Financial Officer Conference Call Participants Operator Good afternoon. My name is John, and I will be your conference operator today.
Neutral
Business Wire
●
4 months ago
SCHAUMBURG, Ill.--(BUSINESS WIRE)--PERDOCEO EDUCATION CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS.
Neutral
Business Wire
●
5 months ago
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Hanna Skandera Joins Perdoceo Education Corporation Board of Directors.
Neutral
Business Wire
●
5 months ago
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Perdoceo Education Corporation Schedules Fourth Quarter Earnings Conference Call for February 18th.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
